Department of Gastroenterology and Hepatology, University Hospital Zürich, Zürich, Switzerland.
Digestive Function: Basel, Laboratory and Clinic for Motility Disorders and Functional Digestive Diseases, Arlesheim, Switzerland.
Neurogastroenterol Motil. 2021 Apr;33(4):e14120. doi: 10.1111/nmo.14120. Epub 2021 Mar 17.
The Chicago Classification v4.0 (CCv4.0) is the updated classification scheme for esophageal motility disorders using metrics from high-resolution manometry (HRM). A key feature of CCv.4.0 is the more rigorous and expansive protocol that incorporates single wet swallows acquired in different positions (supine, upright) and provocative testing, including multiple rapid swallows and rapid drink challenge. Additionally, solid bolus swallows, solid test meal, and/or pharmacologic provocation can be used to identify clinically relevant motility disorders and other conditions (eg, rumination) that occur during and after meals. The acquisition and analysis for performing these tests and the evidence supporting their inclusion in the Chicago Classification protocol is detailed in this technical review. Provocative tests are designed to increase the diagnostic sensitivity and specificity of HRM studies for disorders of esophageal motility. These changes attempt to minimize ambiguity in prior iterations of Chicago Classification, decrease the proportion of HRM studies that deliver inconclusive diagnoses and increase the number of patients with a clinically relevant diagnosis that can direct effective therapy. Another aim in establishing a standard manometry protocol for motility laboratories around the world is to facilitate procedural consistency, improve diagnostic reliability, and promote collaborative research.
芝加哥分类第四版(CCv4.0)是使用高分辨率测压法(HRM)的食管动力障碍更新分类方案。CCv.4.0 的一个关键特征是更严格和广泛的方案,该方案纳入了在不同体位(仰卧位、直立位)下单次湿吞咽以及激发试验,包括多次快速吞咽和快速饮水挑战。此外,还可以使用固体团块吞咽、固体试验餐和/或药物激发来识别在进餐期间和之后发生的具有临床意义的动力障碍和其他情况(例如,反刍)。执行这些测试的采集和分析以及支持将其纳入芝加哥分类方案的证据在本技术综述中详细介绍。激发试验旨在提高 HRM 研究对食管动力障碍的诊断灵敏度和特异性。这些变化试图减少芝加哥分类之前迭代中的歧义,减少提供不确定诊断的 HRM 研究比例,并增加具有可指导有效治疗的临床相关诊断的患者数量。在世界各地的动力实验室建立标准测压协议的另一个目的是促进程序一致性、提高诊断可靠性和促进合作研究。